Dr. Aï Miyamoto, assistant professor at Okayama University, shares her remarkable journey from academia to groundbreaking cancer research. In this interview, she discusses her career, her innovative research, and the recognition she recently received for her work, shedding light on the challenges and rewards of pursuing scientific innovation.
...
Toutes les actualités
Our interviews
- Toutes les catégories :
- Our articles
- Our call for projects
- Our interviews
4 February 2025 Discover our new Interview !
Discover our new serie of interview !
We are delighted to launch a series highlighting the women and men behind IMS. Through these videos, we invite you to meet the directors who, with their expertise and dedication, are shaping the future of our institute.To kick off this series, we invite you to discover Ghislain Auclair, Director of Valorization at IMS. On the agenda:...
9 January 2025 Assessment and Retrospective: The First Two Remarkable Years of IMS
Take a look back at two remarkable years for the Institute of Medicine and Science (IMS), filled with scientific achievements, recognitions, and innovative initiatives.
2021: A Year of Launches and Recognitions
(March_2021:_Prestigious_Grant_for_Alexandre_Detappe_))Alexandre Detappe was awarded the ERC Starting Grant 2020...
5 November 2024 IMS is hosting its workshops on November 14th and 21st
Join the IMS Workshop about "Nanomedicine for drug delivery and imaging" on November 14th
On November 14, IMS invites you to a workshop on nanomedicine for drug delivery and imaging. Led by Dr. Alexandre Detappe and Pr. Dominique Bagnard, this event will feature several experts who will share their research and insights.If you're interested in this event,...
23 September 2024 An evaluation result, indicator of excellence
In July 2024, the IMS was given the highest score being an A by the Interdisciplinary Thematic Institutes during its mid-term evaluation.
What are the ITI (Interdisciplinary thematic institutes) ?
The ITI are the pilar of the research and training evolution of the University of Strasbourg. Lead by an international jury, the midterm evaluation is renewing the 13...
17 September 2024 INEDIS call for project
Inedis is the cornerstone of the innovation and technology transfer of the IMS Group.
This year, we will notice it !
Actually, the Inedis call for proposal is willing to finance of up to 50K euro maximum several excellent projects dealing with development of active molecules/new concepts in any therapeutic areas, and furthermore : Technological projects/...
16 September 2024 Seminar at Okayama University
Dominique bagnard invited as speaker
On Thursday, 19 September, Dominique Bagnard will be in Tokyo to give a summary of the "Biotechnologies - Organoids on a chip - Openings to improved drug testing and to reduction of animal sacrifice". The talk will briefly introduce organoids, with focus on what they are and how they can be fabricated.This seminar is open to all,...
30 August 2024 Application to the Research and Therapeutic Innovation university diploma is open !
The...
12 July 2024 Library IMS: the new pharmaceutical revolution
What if you could find all the resources you need to make your research project a real success? It's now possible with the IMS Library, with 578 different compounds in stock and ready to be targeted!
What exactly is the IMS library?
A collection of chemical compounds designed for use in pharmaceutical research, the IMS library has become an indispensable tool in the...
10 July 2024 Biodol Therapeutics raises €7 million to bring its next-generation pain therapy to the clinic!
Biodol Therapeutics, an innovative French start-up founded by Didier Rognan, Research Director at the CNRS, Director of the Laboratoire d'Innovation Thérapeutique and member of Strasbourg's Institut du Médicament, has successfully raised €7 million to advance its next-generation pain therapy into clinical trials.Specializing in the development of cutting-edge pain relief treatments,...